David Domzalski
2020
In 2020, David Domzalski earned a total compensation of $2.9M as President and Chief Executive Officer at VYNE Therapeutics.
Compensation breakdown
| Bonus | $277,200 |
|---|---|
| Option Awards | $756,908 |
| Salary | $500,500 |
| Stock Awards | $1,326,000 |
| Other | $11,400 |
| Total | $2,872,008 |
Domzalski received $1.3M in stock awards, accounting for 46% of the total pay in 2020.
Domzalski also received $277.2K in bonus, $756.9K in option awards, $500.5K in salary and $11.4K in other compensation.
Rankings
In 2020, David Domzalski's compensation ranked 4,032nd out of 13,090 executives tracked by ExecPay. In other words, Domzalski earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,032 out of 13,090 | 69th |
Division Manufacturing | 1,626 out of 5,624 | 71st |
Major group Chemicals And Allied Products | 622 out of 2,257 | 72nd |
Industry group Drugs | 535 out of 1,957 | 73rd |
Industry Pharmaceutical Preparations | 408 out of 1,462 | 72nd |
Source: SEC filing on June 7, 2021.
Domzalski's colleagues
We found three more compensation records of executives who worked with David Domzalski at VYNE Therapeutics in 2020.
News
VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
November 12, 2024
VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
November 13, 2023
VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
June 17, 2022
VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
June 7, 2021